Rachel Erichson

Rachel Erichson is an accomplished marketing professional currently serving as Associate Director of Access and Payer Marketing at argenx since June 2024. Prior to this role, Rachel held the position of Senior Manager in Market Research at Amgen from October 2023 to June 2024 following Amgen's acquisition of Horizon Therapeutics. At Horizon, Rachel worked from June 2021 to October 2023, where responsibilities included collaborating with marketing to convert business inquiries into research studies and providing key insights for the launch of TEPEZZA, a major rare disease therapy. Rachel's experience also includes managing market access strategies at PRECISIONadvisors between June 2018 and June 2021 and various roles in healthcare economics and market research early in the career, including positions at BlueCross BlueShield of Western New York and KJT Group. Rachel holds a Bachelor of Arts in Epidemiology from the University of Rochester.